Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/1822/79599 |
Resumo: | Available online 13 September 2022 |
id |
RCAP_ef902b1dbe12d5bb5a8f97c5eb7850ea |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/79599 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulationPreformulationDesign of experimentsLevofloxacinNanostructured lipid carrierSolid stateDegradationScience & TechnologyAvailable online 13 September 2022The first step of a successful nanoformulation development is preformulation studies, in which the best excipients, drug-excipient compatibility and interactions can be identified. During the formulation, the critical process parameters and their impact must be studied to establish the stable system with a high drug entrapment efficiency (EE). This work followed these steps to develop nanostructured lipid carriers (NLCs) to deliver the antibiotic levofloxacin (LV). The preformulation studies covered drug solubility in excipients and thorough characterization using thermal analysis, X-ray diffraction and spectroscopy. A design of experiment based on the process parameters identified nanoparticles with < 200 nm in size, polydispersity <=0.3, zeta potential -21 to -24 mV, high EE formulations (> 71%) and an acceptable level of LV degradation products (0.37-1.13%). To the best of our knowledge, this is the first time that a drug degradation is reported and studied in work on nanostructured lipids. LV impurities following the NLC production were detected, mainly levofloxacin N-oxide, a degradation product that has no antimicrobial activity and could interfere with LV quantification in spectrophotometric experiments. Also, the achievement of the highest EE in lipid nanoparticles than those described in the literature to date and the apparent protective action of NLC of entrapped-LV against degradation are important findings.This study was part-financed by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001, CAPES-PrInt, Santander – Program of International Mobility number 31/2018 and Sao Paulo Research Foundation (FAPESP) grant numbers 2018/03666-3, 2019/09719-4 and 2020/08059-8. LT and AU acknowledge funding from Science Foundation Ireland, grants 15/CDA/3602 and 12/RC/2275_P2.info:eu-repo/semantics/publishedVersionElsevierUniversidade do MinhoAraújo, Viviane Lucia Beraldo deVicente, Ana Flávia SiqueiraLima, Marcelo van VlietUmerska, AnitaSouto, Eliana Maria BarbosaTajber, LidiaNascimento, Laura de Oliveira2022-10-152022-10-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/79599engAraújo, Viviane; Vicente, Ana Flávia Siqueira; Lima, Marcelo van Vliet; Umerska, Anita; Souto, Eliana B.; Tajber, Lidia; Nascimento, Laura de Oliveira, Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation. International Journal of Pharmaceutics, 626(122193), 20220378-517310.1016/j.ijpharm.2022.12219336108993122193http://www.elsevier.com/locate/issn/03785173info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:50:07Zoai:repositorium.sdum.uminho.pt:1822/79599Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:48:46.355629Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
title |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
spellingShingle |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation Araújo, Viviane Lucia Beraldo de Preformulation Design of experiments Levofloxacin Nanostructured lipid carrier Solid state Degradation Science & Technology |
title_short |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
title_full |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
title_fullStr |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
title_full_unstemmed |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
title_sort |
Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation |
author |
Araújo, Viviane Lucia Beraldo de |
author_facet |
Araújo, Viviane Lucia Beraldo de Vicente, Ana Flávia Siqueira Lima, Marcelo van Vliet Umerska, Anita Souto, Eliana Maria Barbosa Tajber, Lidia Nascimento, Laura de Oliveira |
author_role |
author |
author2 |
Vicente, Ana Flávia Siqueira Lima, Marcelo van Vliet Umerska, Anita Souto, Eliana Maria Barbosa Tajber, Lidia Nascimento, Laura de Oliveira |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Araújo, Viviane Lucia Beraldo de Vicente, Ana Flávia Siqueira Lima, Marcelo van Vliet Umerska, Anita Souto, Eliana Maria Barbosa Tajber, Lidia Nascimento, Laura de Oliveira |
dc.subject.por.fl_str_mv |
Preformulation Design of experiments Levofloxacin Nanostructured lipid carrier Solid state Degradation Science & Technology |
topic |
Preformulation Design of experiments Levofloxacin Nanostructured lipid carrier Solid state Degradation Science & Technology |
description |
Available online 13 September 2022 |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10-15 2022-10-15T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/1822/79599 |
url |
https://hdl.handle.net/1822/79599 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Araújo, Viviane; Vicente, Ana Flávia Siqueira; Lima, Marcelo van Vliet; Umerska, Anita; Souto, Eliana B.; Tajber, Lidia; Nascimento, Laura de Oliveira, Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation. International Journal of Pharmaceutics, 626(122193), 2022 0378-5173 10.1016/j.ijpharm.2022.122193 36108993 122193 http://www.elsevier.com/locate/issn/03785173 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799133067311316992 |